Teva/Ivax Merger Spurs FTC Information Request
This article was originally published in The Pink Sheet Daily
Executive Summary
The companies continue to expect the transaction to close in late 2005 or early 2006.
You may also be interested in...
Limited ANDA Overlap With Ivax Creates Strong Position For Part D Benefit, Teva Says
There is "substantial non-overlap" between Teva's and Ivax' abbreviated new drug applications, Teva North America CEO George Barrett said
Lipitor Pricing Offsets Loss In Prescription Volume, Pfizer Says
Declines in Lipitor's prescription volume due to the presence of generic simvastatin are being offset by price increases, Pfizer says
Mail-Order Pharmacy Not Necessarily Cheaper To Health Plans, Ohio Finds
Health plans should account for the rise in utilization that occurs with use of mail-order pharmacy when deciding if mail order saves money, Ohio Public Employees Retirement System Director of Healthcare Scott Streator said at the recent Academy of Managed Care Pharmacy Educational Conference in Chicago